Compare SPRO & DLTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SPRO | DLTH |
|---|---|---|
| Founded | 2013 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 156.3M | 138.0M |
| IPO Year | 2017 | 2015 |
| Metric | SPRO | DLTH |
|---|---|---|
| Price | $1.20 | $4.33 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | ★ 2.0M | 91.4K |
| Earning Date | 05-13-2026 | 06-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 111.81 | 64.12 |
| EPS | ★ N/A | N/A |
| Revenue | $66,802,000.00 | ★ $565,184,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $300.00 | $2.80 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 39.24 | N/A |
| 52 Week Low | $1.08 | $2.02 |
| 52 Week High | $3.08 | $5.09 |
| Indicator | SPRO | DLTH |
|---|---|---|
| Relative Strength Index (RSI) | 22.37 | 53.34 |
| Support Level | N/A | $3.95 |
| Resistance Level | $2.44 | $4.76 |
| Average True Range (ATR) | 0.16 | 0.21 |
| MACD | -0.05 | -0.02 |
| Stochastic Oscillator | 10.32 | 52.50 |
Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. It is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.
Duluth Holdings Inc is an apparel brand in the United States. The company offers shirts, pants, and casual wear for men and women under brands like Alaskan Hardgear, Armachillo, Ballroom, Cab Commander, Crouch Gusset, Dry on the Fly, Duluth Trading Co, Duluthflex, Fire Hose, Longtail T, No Polo Shirt, No Yank, Wild Boar, and others. The Company's revenue consists of the sale of apparel, footwear, and hard goods. The company operates in a single operating segment.